Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Priority review granted to Femara as first-line breast cancer therapy

Sep. 13, 2000

Synthesis and activity of novel PTK inhibitors reported by U.S. university researchers

Sep. 13, 2000

SRI presents novel steroid mimics useful for breast cancer

Sep. 13, 2000

BASF grants exclusive licenses for oncolytic compounds to Ilex

Sep. 13, 2000

Kyowa Hakko reports new series of proteasome inhibitors

Sep. 12, 2000

Novel inhibitors of tyrosine kinase from Merck useful for angiogenesis-related disorders

Sep. 12, 2000

French institutes join forces to design pseudopeptide MMP inhibitors

Sep. 12, 2000

Antiproliferative Ca2+ channel blockers and SAR reported by U. Virginia

Sep. 12, 2000

New taxoid RPR-109881A evaluated in phase I trial in patients with solid tumors

Sep. 12, 2000

Yamanouchi discovers naturally occurring cytotoxic depsipeptide

Sep. 8, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...